1. Aigner, TG, and Mishkin, M: The effects of physostigmine and scopolamine on recognition memory in monkeys. Behav. Neural. Biol., 45:81–87, 1986.
2. Aigner, TG, Walker, DL, and Mishkin, M: Comparison of the effects of scopolamine administered before and after acquisition in a test of visual recognition memory in monkeys. Behav. Neural. Biol., 55:61–67, 1991.
3. Albert, MS: Cognitive Function, in Geriatric Neuropsychology, edited by Albert, MS, and Moss, MR, New York, Guilford Press, 1988, pp. 33–53.
4. Albert, M, and Moss, M: The assessment of memory disorders in patients with Alzheimer disease, in Neuropsychology of Memory, edited by Squire, LR, and Butters, NE, New York, Guilford Press, 1992, pp. 236–246.
5. Antonini, A, and Leenders, KL: Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11]C-raclopride. Ann. N.Y. Acad. Sci., 695:81–85, 1993.